NCT06626490 Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants
| NCT ID | NCT06626490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aesculap AG |
| Condition | Revision Total Hip Arthroplasty |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-04-07 |
| Primary Completion | 2033-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-04-07 with a primary completion date of 2033-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.
Eligibility Criteria
Inclusion Criteria: * Revision hip arthroplasty patients treated with a Prevision hip stem * Written patient informed consent * Patients are able to attend at follow-up examinations Exclusion Criteria: * Patients \< 18 years at surgery * Pregnancy at implantation * Patients held in a custodial setting * Patients in a relationship of dependence on the sponsor, the clinic or the investigator
Contact & Investigator
Henning Windhagen, Prof. Dr.
PRINCIPAL INVESTIGATOR
Orthopädische Kliniken im Annastift, MHH
Frequently Asked Questions
Who can join the NCT06626490 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Revision Total Hip Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06626490 currently recruiting?
Yes, NCT06626490 is actively recruiting participants. Contact the research team at studies@aesculap.de for enrollment information.
Where is the NCT06626490 trial being conducted?
This trial is being conducted at Hanover, Germany, Huntingdon, United Kingdom.
Who is sponsoring the NCT06626490 clinical trial?
NCT06626490 is sponsored by Aesculap AG. The principal investigator is Henning Windhagen, Prof. Dr. at Orthopädische Kliniken im Annastift, MHH. The trial plans to enroll 120 participants.